Piermont Capital Management Inc. - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,412,000
-36.2%
116,005
-16.6%
0.45%
-36.0%
Q4 2015$2,212,000
+2.8%
139,020
-1.0%
0.70%
+0.1%
Q3 2015$2,152,000
-36.0%
140,360
+1.4%
0.70%
-30.8%
Q2 2015$3,364,000
+24.2%
138,380
+18.8%
1.02%
+23.0%
Q1 2015$2,709,000
+661.0%
116,520
+722.3%
0.82%
+549.6%
Q4 2014$356,00014,1700.13%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 462,824$7,364,0008.63%
HealthCor Management, L.P. 1,750,000$27,843,0001.69%
ACUTA CAPITAL PARTNERS, LLC 144,667$2,302,0001.10%
THB ASSET MANAGEMENT 615,546$9,793,0001.05%
Penn Capital Management Company, LLC 1,399,205$22,261,0000.98%
Tamarack Advisers, LP 450,000$7,160,0000.94%
Piermont Capital Management Inc. 139,020$2,212,0000.70%
JW Asset Management, LLC 101,630$1,617,0000.60%
SECTORAL ASSET MANAGEMENT INC 810,362$12,893,0000.55%
Glacier Peak Capital LLC 50,000$796,0000.51%
View complete list of SAGENT PHARMACEUTICALS INC shareholders